Erythropoietin
Janessa Smith, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Anemia secondary to chronic kidney disease (CKD).
- Anemia secondary to AZT and low erythropoietin levels in HIV+ pts.
- Anemia secondary to chemotherapy.
- Reduction of allogenic blood transfusion in pts with significant blood loss during surgery.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Anemia without correctable cause in HIV+ pts w/ low erythropoietin levels (< 500 IU/L).
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.